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Abstract
Kohlschütter–Tönz syndrome (KTS) is a rare autosomal recessive disorder characterized by
amelogenesis imperfecta, psychomotor delay or regression and seizures starting early in
childhood. KTS was established as a distinct clinical entity after the first report by Kohlschütter in
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1974, and to date, only a total of 20 pedigrees have been reported. The genetic etiology of KTS
remained elusive until recently when mutations in ROGDI were independently identified in three
unrelated families and in five likely related Druze families. Herein, we report a clinical and
genetic study of 10 KTS families. By using a combination of whole exome sequencing, linkage
analysis, and Sanger sequencing, we identify novel homozygous or compound heterozygous
ROGDI mutations in five families, all presenting with a typical KTS phenotype. The other
families, mostly presenting with additional atypical features, were negative for ROGDI mutations,
suggesting genetic heterogeneity of atypical forms of the disease.
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Kohlschütter–Tönz syndrome (KTS; MIM #226750), first described in 1974 by
Kohlschütter et al. in a Swiss family [Kohlschutter et al., 1974], is a rare autosomal
recessive neurodegenerative syndrome characterized by a combination of features that
include epilepsy, developmental delay and the most distinctive feature of amelogenesis
imperfecta (yellow teeth with abnormal enamel). To date, 15 pedigrees have been reported
in the literature, mostly consistent with an autosomal recessive mode of inheritance
[Christodoulou et al., 1988; Donnai et al., 2005; Guazzi et al., 1994; Haberlandt et al., 2006;
Kohlschutter et al., 1974; Mory et al., 2012; Musumeci et al., 1995; Petermoller et al., 1993;
Schossig et al., 2012a; Wygold et al., 1996; Zlotogora et al., 1993]. The major clinical
features of KTS include early onset seizures (between birth and 3 years of age) that are
usually treatment resistant with various antiepileptic agents, psychomotor delay or
regression starting in infancy, spasticity of the upper and lower limbs, and the
developmental enamel defect (amelogenesis imperfecta) affecting both primary and
secondary dentition. The enamel is thin and rough, and the teeth are yellow and prone to
crumble. The teeth abnormalities seen (yellow amelogenesis imperfecta) would seem
pathognomonic but similar tooth abnormalities have been reported in association with other
complex neurological phenotypes [Linssen, et al., 1994]. Recently, Schossig et al. [2012a]
and Mory et al. [2012] identified mutations in ROGDI (MIM #614574), a gene encoding a
protein of currently unknown function, in several families with typical features of KTS. We
present 10 families (six previously reported) with KTS or a phenotype that was very similar
to KTS with the core features of epilepsy, developmental delay, and abnormal teeth affected
by amelogenesis imperfecta. A combination of linkage analysis, exome sequencing, and
Sanger sequencing identified novel mutations in ROGDI in five of these families.
Written informed consent was obtained from all families before sample collection and
institutional ethics approval was also obtained. The family trees are illustrated in Figure 1A.
The clinical details from each family are described below.
Family A: This family has been reported in 1988 [Christodoulou et al., 1988]. The
parents originate from a small isolated town in Sicily. The affected individuals (six
siblings) all had a similar phenotype characterized by delayed neuromotor development,
epilepsy (onset between 7 and 22 months), and amelogenesis imperfecta of the
hypoplastic rough type.
Family B: This is a new case of KTS originating from Germany. The affected boy was
the first child of healthy nonconsanguineous parents; the pedigree is unremarkable. He
was born after an uneventful pregnancy and his development was normal during the
first half year of his life. At age 7 months, the boy presented with treatment resistant
seizures followed by severe delay of motor and cognitive development. The primary
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dentition revealed yellow teeth with severe enamel defects. At the age of 2 years and 4
months, the boy had small stature (48 cm, −2.3 SD) and microcephaly.
Family C: This family has been reported in 1995 [Musumeci et al., 1995]. Briefly, it
consists of two affected siblings (male and female) born from consanguineous parents
(first degree cousins) of Sicilian origin. They had their first seizures between the age of
2 and 10 months, developed psychomotor regression starting at 2 years of age, and had
yellow teeth with very thin and hypoplastic enamel. Presence of broad thumbs and toes
is reported.
Family D: This family has been reported by Petermoller et al., [1993]. Briefly, the
parents in this family are unrelated and of German origin. They had two affected
children. Both had their first epileptic seizures at the age of 8 months, yellow teeth with
amelogenesis imperfecta, and regression of psychomotor development starting at birth.
One of the children died at the age of 21 years.
Family E: This family has been reported in 2012 [Schossig et al., 2012b]. The affected
boy was the first child of healthy, unrelated parents of German origin and has two
healthy sisters. He was born at term after an uneventful pregnancy and his development
was normal until he had his first seizures at the age of 11 months. After that he showed
delay of psychomotor development and partial regression of motor skills. His epilepsy
was difficult to treat. His teeth showed a brownish discoloration.
Family F: This family from the USA has not been previously reported. The child
presented at 8 months of age with seizures and was found to have infantile spasms. MRI
of the brain was normal. He went on to have profound developmental handicaps,
developed spasticity in all four extremities, and had intractable mixed focal onset and
generalized myoclonic/tonic epilepsy. He was noted to have amelogenesis imperfecta as
his teeth erupted and they were yellow. Spasticity has been treated with baclofen and he
required bilateral femoral osteotomies for hip dislocations and spinal rod placement for
scoliosis. At the age of 15, he was inconsistently visually interactive and has no
expressive language; he was unable to sit or roll over.
Family G: This family of Scilian origin has been reported in 1994 [Guazzi et al., 1994].
This pedigree was complicated, with four different phenotypes occurring concurrently:
amelogenesis imperfecta only, delayed psychomotor development, ataxia, and abnormal
EEG, as well as neurological disorder or seizures and amelogenesis imperfecta. This
family was atypical for KTS, given the later age at onset and the teeth affected by
amelogenesis imperfecta being not truly yellow with missing enamel. Additionally, the
inheritance looked dominant in this family but on the contrary, affected individuals
from the last generation are born from first-degree cousins parents. It is possible that
more than just one disorder is responsible for the complex phenotypes in this pedigree
as there were individuals suffering only from amelogenesis imperfecta.
Family H: This English family has been previously reported by Donnai et al. [2005],
and comprised of two affected siblings from healthy unrelated parents. Both siblings
developed seizures at the age of 5 weeks (male) and 11 weeks (female), delayed
psychomotor development starting at the age of 1 year, and yellow teeth with
hypoplastic and hypomineralized enamel. They also had feeding problems with multiple
food intolerances. The affected female was also clinically and genetically diagnosed
with neurofibromatosis type 1.
Family I: This patient from the Netherlands is the second of two children born to
healthy unrelated parents. He followed a delayed motor and cognitive development.
Both primary and secondary dentition showed absent enamel of several but not all teeth.
A brain MRI showed mild atrophy of the cranial part of the vermis and small pons, but
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was otherwise normal. Although he had periods of unusual quiet behavior and
sleepiness thereafter true convulsions were not recognized. EEG studies showed
multiple epileptiformic activities, mainly frontal and frontotemporal. Unusual
morphological features were deeply set eyes, horizontal eyebrows, short nose, concave
nasal ridge, anteverted nares, irregularly placed teeth, many of which without enamel,
small ears, and mild hypermobility of the small joints. He had multiple warts.
Family J: This patient originating form the Netherlands showed a mildly delayed global
development after normal pregnancy and delivery. Parents are unrelated. The girl had
several episodes suggestive of epilepsy from the age of 18 months. A definitive
diagnosis of epilepsy was made at the age 6 years. She had a variety of seizures types
including atypical absence and myoclonic types. EEG showed continuous spike waves
during sleep. Epilepsy was resistant to therapy. Her teeth were first white but discolored
some time after eruption. The diagnosis of amelogenesis imperfecta was made by a
pediatric dentist. Currently she has mild intellectual disability. Neurological
examination shows no abnormalities besides mild clumsiness.
Linkage analysis was carried out as part of a previous PhD thesis [Lo, 2009] in families A,
C, D, G, and H, and revealed a linkage peak (LOD score = 3.05) at D16S423 (chromosome
16) in parametric linkage analysis for the combined families, considering mode of
inheritance as recessive (Supp. Table S1). Further evidence of a disease locus at 16p13.3–
13.2 was provided by haplotype analysis of families A, C, and D and also by whole genome
SNP genotyping on affected individuals from families A and C, which revealed a shared a
region of homozygosity on the telomeric arm of chromosome 16 (data not shown).
Given the large number of genes in the linked region, we performed whole exome
sequencing on affected individuals from families A, C, D, and I (Fig. 1; Table 1). All
samples were enriched using the Illumina TruSeq exome capture system and sequenced on
an Illumina HiSeq 2000 except of the proband from family C who was run using the
Nimblegen SeqCap EZ enrichment kit and sequenced on one flowcell on the Illumina
Genome Analyzer IIx (Supp. Table S2 for details on whole exome sequencing summary
metrics). Using an allele frequency cutoff of 1% (based on both the 1,000 Genomes project
and the NHLBI exome variant server), we found a novel homozygous putative pathogenic
mutation in the linked region on chromosome 16 within the ROGDI gene in the affected
individual from Family A (c.507delC, p.Glu170Argfs*72). The remaining exome sequence
data from families C, D, and I did not identify additional rare variants in ROGDI though an
in depth analysis showed that some of the ROGDI exons were not well covered (mainly
exons 1 and 2). As ROGDI mutations were independently identified in KTS families at that
time [Mory et al., 2012; Schossig et al., 2012a], we performed Sanger sequencing of all
coding exons, exon–intron boundaries, and the short introns 1, 3, 8, 9, and 10 of ROGDI in
all available, unresolved families (primers as published by Schossig et al., 2012). Mutations
were named based on the Gen-Bank reference sequences with accession numbers
NM_024589.2 and NP_078865.1; nucleotide numbering reflects cDNA numbering with +1
corresponding to the A of the ATG translation initiation codon (codon 1) in the reference
sequence. Novel variants detected were submitted to the Leiden Open Variation database
(http://www.lovd.nl/ROGDI).
We identified ROGDI mutations in five out of 10 families analyzed. We confirmed the
homozygous 1-bp deletion (c.507delC) in family A and found the same mutation
homozygous in the affected child from family B. Both parents were confirmed to be
heterozygous. Quantitative RT-PCR in the affected child from family B showed a marked
reduction of the amount of ROGDI transcript to about 25% compared with controls (data not
shown), indicating nonsense-mediated decay. Affected individuals in families C and D
carried two different homozygous deletions in intron 1: c.46−37_46−30del and c.
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45+9_45+20del, respectively (Fig. 1B). The mutations were found heterozygous in the
parents. The presence of these deletions was confirmed through fragment analysis (Supp.
Fig. S2). The affected individual from family E was compound heterozygous for the deletion
c.45+9_45+20del in intron 1 and a 1-bp duplication c.366dupA predicted to result in a
frameshift with a premature stop codon after 19 amino acids, denoted p.Ala123Serfs*19.
The father of this patient was heterozygous for c.366dupA and the mother for c.
45+9_45+20del. Quantitative RT-PCR with specific primers spanning ROGDI exons 3–5, as
previously described [Schossig et al., 2012a], showed a reduction of ROGDI transcripts to
about 55% and 60% in both the mother and the affected child, respectively, when compared
with controls (data not shown), whereas it did not show any reduction in the father.
To investigate the effect of c.45+9_45+20del on pre-mRNA processing we designed an RT-
PCR primer pair that preferentially amplifies transcripts of the maternal allele in the affected
child (see Supp. Methods section for details). We obtained an RT-PCR product around 60
bp longer than the wild-type RT-PCR products (Fig. 1C). Sequencing of this longer product
showed retention of the mutated 61-bp intron 1 lacking the 12 deleted base pairs (Fig. 1C).
This confirms that the deletion c.45+9_45+20del prevents recognition of intron 1 by the
splicing machinery and leads to frameshift and creation of a premature stop codon
(p.Glu16Valfs*57) in exon 3.
We failed to identify any putative ROGDI mutations in families F, G, H, I, and J. In
addition, ROGDI expression levels in the affected from family J and his parents were
comparable to those in normal controls and also direct cDNA sequencing did not uncover a
ROGDI mutation. Independent genetic analyses in the proband from family I revealed a
2.75Mb de novo duplication on chromosome 7 (hg18 coordinates chr7: 5,100,000–
7,855,000) (Supporting Information and Supp. Fig. S2).
In summary, the identification of a novel homozygous frameshift deletion (family A and
family B) and the novel intronic short deletions (families C, D, and E) (one of which was
confirmed to affect splicing in family E), all segregating with disease, fully supports the fact
that bi-allelic loss-of-function variants in the gene ROGDI cause KTS and confirm the
results of Schossig et al. [2012a] and Mory et al. [2012]. These families had typical KTS,
and three of them had previously been linked to chromosome 16 in the region of the ROGDI
locus.
Our results further emphasize the importance of sequencing non-coding regulatory regions,
at least to within 20 bp of the exon for the analysis of Mendelian disorders. In particular, the
intronic deletion c.45+9_45+20del is interesting as it is not a typical splice site mutation and
prediction programs available through ALAMUT did not predict a significant alteration of
splicing. The molecular mechanism in which this deletion disrupts the recognition of the
already short intron 1 is unclear. Another important lesson from this study is that exome
sequencing did not identify these intronic deletions, even though they were 20 bp away from
the exon boundaries, perhaps because the region is repetitive and GC rich.
In five KTS families (families F, G, H, I, and J), no mutations were found in ROGDI.
Clinically these families had an atypical KTS phenotype as they had additional features,
except for the affected of family J who had a rather mild phenotype. Family F had spasticity.
Family G presented late, had a likely dominant pattern of inheritance and teeth that were
amelogenic but not truly yellow. The affected individuals from family H had all the features
of KTS but were unusual in that they also had feeding difficulties, and family I had
additional dysmorphic features. These clinical differences reflect that so far ROGDI
mutations have been identified only in typical KTS cases. Even though the phenotype is
complex, our data indicate that there may be a relatively specific pattern of clinical features
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associated with mutations in this gene. Although we cannot rule out difficult to detect deep
intronic mutations or compound heterozygous exonic copy number variations, this is
improbable in families G and Has they did not share the same haplotypes on chromosome
16p13.3–13.2. Additionally, in family J additional RT-PCR sequencing was unremarkable in
the affected individual and quantitative RT-PCR showed no reduction of mRNA. Our data
indicate that atypical phenotypes of KTS are more likely due to mutations of other genes;
indeed, extensive genetic analysis in the proband from family I (whole exome sequencing
and CGH array) led to the identification of a de novo 2.75 Mb duplication on chromosome
7, comprising about 60 genes (NCBI mapviewer). It is likely that a dosage effect of one of
the genes in this region is causing a KTS-like phenotype, although this was not seen in any
of the other families.
To conclude, we have confirmed that a typical KTS phenotype [Schossig et al., 2012b] is
generally caused by loss of function mutations in ROGDI and identified intronic deletions in
ROGDI that were missed using whole exome sequencing. A number of families with
atypical KTS phenotype were negative for ROGDI mutations and failed to show
homozygosity in the ROGDI region, suggesting genetic heterogeneity of atypical forms of
the disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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A: Family trees. Circles indicate samples that underwent whole exome sequencing. AI,
amelogenesis imperfecta; KTS, Kohlschütter– Tönz syndrome. B: Gene structure with
location of mutations and chromatograms showing the mutations reported in this
manuscript. Black/above gene: previously reported mutations. Red/below: novel mutations
reported in the present manuscript. Curly brackets and red arrow indicate deleted nucleotides
in affected members. C: ROGDI transcript analyses in family E. (a) RT-PCR products
generated with awild-type specific reversed primer in exon 6. The mother (M) shows a
strong 400 bp wild-type amplicon and an aberrant approximately 460 bp band. The wild-
type band is also found in the father (F) and the control (C). The affected child (P) shows
predominantly the aberrant 460 bp band. All samples have an additional band of
approximately 340 bp, which represents a small fraction of transcripts skipping of exon 4 as
deduced from sequencing analysis of the RT-PCR products (data not shown). L, size
standard. (b) Sequence of the RT-PCR product of the ROGDI transcripts in the affected
child. The mutation c.45+9_45+20del-containing intron 1 is retained between the unaltered
exons 1 and 2.
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